We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

45 hedge funds and large institutions have $8.62M invested in Pear Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 3 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

785% more capital invested

Capital invested by funds: $974K → $8.62M (+$7.64M)

375% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 8

200% more funds holding

Funds holding: 15 → 45 (+30)

Holders
45
Holders Change
+30
Holders Change %
+200%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
3
Reduced
–
Closed
8
Calls
$2.76M
Puts
–
Net Calls
+$2.76M
Net Calls Change
+$2.74M

Top Buyers

Rank Fund Capital Flow
1
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$427K
2
AC
Aristeia Capital
Connecticut
+$349K
3
KCM
Kingstown Capital Management
New York
+$327K
4
KC
Kepos Capital
New York
+$218K
5
GCL
Glazer Capital LLC
New York
+$217K

Top Sellers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
-$201K
2
BFM
Boothbay Fund Management
New York
-$150K
3
OCM
Oribel Capital Management
New York
-$67K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$48K
5
FTCM
Fir Tree Capital Management
New York
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
26
Woodline Partners
California
$70K +$43.7K +50,034 New
Blackstone Inc
27
Blackstone Inc
New York
$62K +$36.4K +41,666 New
AA
28
AQR Arbitrage
Connecticut
$56K +$35.2K +40,333 New
MIM
29
Monashee Investment Management
Massachusetts
$49K +$29.1K +33,332 New
SCC
30
Spring Creek Capital
Kansas
$49K +$29.1K +33,333 New
TCM
31
Tenor Capital Management
New York
$49K +$29.1K +33,333 New
Nomura Holdings
32
Nomura Holdings
Japan
$35K +$21.9K +25,132 New
Parallax Volatility Advisers
33
Parallax Volatility Advisers
California
$27K +$16.2K +18,524 New
Bank of America
34
Bank of America
North Carolina
$25K +$14.5K +16,666 New
CH
35
CVI Holdings
Delaware
$23K – – –
DCM
36
Dupont Capital Management
Delaware
$23K +$14.5K +16,666 New
CAC
37
Cowen and Company
New York
$22K +$13.1K +15,000 New
Walleye Trading
38
Walleye Trading
New York
$20K +$11.6K +13,333 New
ACM
39
Atalaya Capital Management
New York
$12K – – –
VI
40
Vestcor Inc
New Brunswick, Canada
$12K – – –
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$3K +$1.65K +1,889 New
PCM
42
PenderFund Capital Management
British Columbia, Canada
$1K +$291 +333 New
MI
43
MMCAP International
Cayman Islands
$49 +$29.1K +33,333 New
Walleye Capital
44
Walleye Capital
New York
$34 +$19.8K +22,710 New
SCM
45
Saba Capital Management
New York
– -$201K -211,664 Closed
OCM
46
Oribel Capital Management
New York
– -$67K -70,701 Closed
PAMP
47
Polar Asset Management Partners
Ontario, Canada
– -$48K -50,000 Closed
FTCM
48
Fir Tree Capital Management
New York
– -$32K -33,329 Closed
WA
49
Whitebox Advisors
Minnesota
– -$16K -16,766 Closed
BFM
50
Boothbay Fund Management
New York
– -$150K -15,500 Closed
1
2
3

PEARW Hedge Fund Activity: Q2 2021 in Review

45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q2 2021, worth a combined $8.62M — up 785% from $974K a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PEARW positions and 8 closed out — a net gain of 30 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was P. Schoenfeld Asset Management (PSAM), opening a new position worth an estimated $427K. The largest seller was Saba Capital Management, exiting entirely with an estimated $201K sold.

  • 45 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q2 2021, up from 15 in Q1 2021.
  • Funds reported $8.62M of Pear Therapeutics, Inc. Warrant stock for Q2 2021, up 785% quarter-over-quarter.
  • 38 funds opened new Pear Therapeutics, Inc. Warrant positions in Q2 2021 and 8 closed out, a net change of +30 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q2 2021 was P. Schoenfeld Asset Management (PSAM), an estimated $427K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q2 2021 was Saba Capital Management, an estimated $201K sold.

Based on aggregated 13F filings for Q2 2021.